A detailed history of Price T Rowe Associates Inc transactions in National Research Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 13,498 shares of NRC stock, worth $262,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,498
Previous 13,354 1.08%
Holding current value
$262,671
Previous $307,000 0.65%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$20.61 - $26.17 $2,967 - $3,768
144 Added 1.08%
13,498 $309,000
Q2 2024

Aug 14, 2024

BUY
$22.95 - $39.34 $15,330 - $26,279
668 Added 5.27%
13,354 $307,000
Q1 2024

May 15, 2024

BUY
$36.87 - $41.2 $170,966 - $191,044
4,637 Added 57.61%
12,686 $503,000
Q4 2023

Feb 14, 2024

BUY
$39.05 - $46.39 $9,176 - $10,901
235 Added 3.01%
8,049 $319,000
Q3 2023

Nov 14, 2023

BUY
$41.8 - $46.78 $18,684 - $20,910
447 Added 6.07%
7,814 $347,000
Q2 2023

Aug 14, 2023

BUY
$40.78 - $46.7 $6,728 - $7,705
165 Added 2.29%
7,367 $321,000
Q1 2023

May 15, 2023

SELL
$38.17 - $47.17 $93,669 - $115,755
-2,454 Reduced 25.41%
7,202 $314,000
Q4 2022

Feb 14, 2023

BUY
$35.23 - $41.21 $8,138 - $9,519
231 Added 2.45%
9,656 $360,000
Q3 2022

Nov 14, 2022

BUY
$33.58 - $40.66 $28,442 - $34,439
847 Added 9.87%
9,425 $376,000
Q2 2022

Aug 15, 2022

BUY
$31.87 - $40.9 $50,067 - $64,253
1,571 Added 22.42%
8,578 $328,000
Q1 2022

May 16, 2022

BUY
$36.33 - $42.25 $10,245 - $11,914
282 Added 4.19%
7,007 $278,000
Q4 2021

Feb 14, 2022

SELL
$40.05 - $49.0 $9,612 - $11,760
-240 Reduced 3.45%
6,725 $279,000
Q2 2021

Aug 16, 2021

BUY
$43.54 - $51.55 $13,192 - $15,619
303 Added 4.55%
6,965 $320,000
Q1 2021

May 17, 2021

BUY
$42.92 - $54.13 $285,933 - $360,614
6,662 New
6,662 $312,000

Others Institutions Holding NRC

About NATIONAL RESEARCH CORP


  • Ticker NRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 24,767,100
  • Market Cap $482M
  • Description
  • National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...
More about NRC
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.